QUEST DIAGNOSTICS LLC IL NPI 1346389764

NPI Details

QUEST DIAGNOSTICS LLC IL is a clinical medical laboratory in Schaumburg, IL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. QUEST DIAGNOSTICS LLC IL NPI is 1346389764. The provider is registered as an organization entity type.

The provider's business location address is:

506 E STATE PKWY
SCHAUMBURG, IL
ZIP 60173-538
Phone: (708) 885-2010

The provider's authorized official is Leah D Timmerman .
The authorized official title is Vice President and has the following contact phone number (973) 520-2700.

The CLIA number assigned to this NPI record is 14D0416537 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Measurement of rna of bacteria in vaginal fluid specimen (HCPCS:81513)
• Detection test by nucleic acid for hiv-1 virus, quantification (HCPCS:87536)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Detection test by nucleic acid for hepatitis c virus, quantification (HCPCS:87522)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
• Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Detection test by nucleic acid for hepatitis b virus, quantification (HCPCS:87517)
• Detection test by nucleic acid for clostridium difficile, amplified probe technique (HCPCS:87493)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Pap test (HCPCS:88141)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Pap test, manual screening (HCPCS:88142)
• Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Surgical pathology consultation and report on referred slides prepared elsewhere (HCPCS:88321)
• Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)

The enumeration date for this NPI number is 2/5/2007 and was last updated on 1/30/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.